Finance Psyence Biomedical receives delisting choice from Nasdaq Last updated: 15/09/2024 5:28 Sáng admin Published 15/09/2024 Share Psyence Biomedical receives delisting determination from Nasdaq Source link You Might Also Like Aston Martin drops 28% after benefit caution on provide chain, China woes IMF sees slow go back to financial normalcy in Bangladesh EU choices professionals to influence AI compliance laws Platinum Fairness’s Ingram Micro makes US IPO submitting public Unique-Copper output at Freeport’s Manyar smelter not on time till November TAGGED:BiomedicaldelistingdeterminationNasdaqPsyencereceives Share This Article Facebook Twitter Email Copy Link Print Previous Article Gores Holdings IX receives Nasdaq’s delinquency notification letter Next Article Unique-OpenAI’s shocking $150 billion valuation hinges on upending company construction, resources say Follow USFind US on Socials FacebookLikeTwitterFollowYoutubeSubscribeTelegramFollow Subscribe to our newsletternGet Newest Articles Instantly! Your email - Advertisement - Popular News NIDO Workforce expects automation to chop operational prices through round 25% for D2C manufacturers – Business Information BTC Struggles at the $70,000 Resistance – What’s the Next Level to Watch? Spot Ether ETF Approval Proves ETH is Not a Security: Expert Metaplanet Emerges as Top Gainer in Japanese Stocks After Adding Bitcoin to Reserves CryptoPunks Mission Placed on Hang through Yuga Labs Because of ‘Woke’ Group Outcry
